Von Willebrand factor

Active ingredient description

Administration of von Willebrand factor allows correction of the haemostatic abnormalities exhibited by patients who suffer from von Willebrand factor deficiency.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code Group title Classification
B02BD10 Von Willebrand factor B Blood and blood forming organs → B02 Antihemorrhagics → B02B Vitamin K and other hemostatics → B02BD Blood coagulation factors
Discover more medicines within B02BD10

Product monographs

Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):

Title Information Source Document Type  
WILLFACT Powder and solvent for solution for injection Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

External identifiers

CAS Substance: 109319-16-6
DrugBank Drug: DB13133
RxNorm Ingredient: 11274
SNOMED-CT Concept: 18288009
von Willebrand factor (substance)
UNII Identifier: ZE22NE22F1
VON WILLEBRAND FACTOR HUMAN

Medicines

Von Willebrand factor is an active ingredient of these brands:

United States (US)

Austria (AT)

  • VEYVONDI as Von Willebrand factor, Recombinant, Human
  • WILLFACT as Von Willebrand factor from human plasma

  • (combination) HAEMATE as Human von Willebrand factor
  • (combination) VONCENTO
  • (combination) WILATE

Brazil (BR)

Canada (CA)

Croatia (HR)

  • VEYVONDI as Von Willebrand factor, Recombinant, Human

  • (combination) HAEMATE as Human von Willebrand factor
  • (combination) VONCENTO
  • (combination) WILATE

Cyprus (CY)

  • (combination) HAEMATE as Human von Willebrand factor
  • (combination) VONCENTO

Ecuador (EC)

Estonia (EE)

  • VEYVONDI as Von Willebrand factor, Recombinant, Human
  • WILLFACT as Von Willebrand factor from human plasma

  • (combination) HAEMATE as Human von Willebrand factor
  • (combination) VONCENTO
  • (combination) WILATE

Finland (FI)

France (FR)

Hong Kong (HK)

Ireland (IE)

Israel (IL)

  • (combination) HAEMATE as Human von Willebrand factor
  • (combination) WILATE

Italy (IT)

Japan (JP)

Lithuania (LT)

  • VEYVONDI as Von Willebrand factor, Recombinant, Human
  • WILLFACT as Von Willebrand factor from human plasma

  • (combination) VONCENTO
  • (combination) WILATE

Malta (MT)

Netherlands (NL)

New Zealand (NZ)

Poland (PL)

  • VEYVONDI as Von Willebrand factor, Recombinant, Human
  • WILLFACT as Von Willebrand factor from human plasma

  • (combination) HAEMATE as Human von Willebrand factor
  • (combination) VONCENTO
  • (combination) WILATE

Romania (RO)

  • VEYVONDI as Von Willebrand factor, Recombinant, Human

  • (combination) HAEMATE as Human von Willebrand factor
  • (combination) WILATE

Singapore (SG)

Spain (ES)

  • WILLFACT as Von Willebrand factor from human plasma

  • (combination) HAEMATE as Human von Willebrand factor
  • (combination) WILATE

Tunisia (TN)

  • (combination) HAEMATE as Human von Willebrand factor
  • (combination) WILATE

Turkey (TR)

  • (combination) HAEMATE as Human von Willebrand factor

United Kingdom (UK)

  • VEYVONDI as Von Willebrand factor, Recombinant, Human
  • WILLFACT as Von Willebrand factor from human plasma

  • (combination) VONCENTO
  • (combination) WILATE

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.